Elevated liver enzymes in Turner syndrome during a 5-year follow-up study

Clinical Endocrinology

Volumn 68, Issue 3, 2008, Pages 485-490

  El Mansoury, Mostafa ^a   Berntorp, Kerstin ^b   Bryman, Inger ^a   Hanson, Charles ^a   Innala, Eva ^c   Karlsson, Anders ^d   Landin Wilhelmsen, Kerstin ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANDROGEN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; ASPARTIC ACID; AUTOANTIBODY; BILIRUBIN; CHOLESTEROL; CYANOCOBALAMIN; ESTRADIOL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GROWTH HORMONE; HORMONE; LIPID; LIVER ENZYME; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CHOLANGITIS; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; FATTY LIVER; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN TISSUE; INCIDENCE; KARYOTYPE 45,X; LIPOPROTEIN BLOOD LEVEL; LIVER; LIVER BIOPSY; MAJOR CLINICAL STUDY; METABOLISM; MULTIVARIATE ANALYSIS; OUTPATIENT DEPARTMENT; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; TURNER SYNDROME; UNIVERSITY HOSPITAL; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; MIDDLE AGED; TURNER SYNDROME; YOUNG ADULT;

EID: 39149141050     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03166.x     Document Type: Article

References (26)

1. Lippe, B. (1991) Turner syndrome. Endocrinology and Metabolism Clinics of North America, 20, 121 152.
2. Elsheikh, M., Wass, J.A.H. Conway, G.S. (2001) Autoimmune thyroid syndrome in women with Turner's syndrome - the association with karyotype. Clinical Endocrinology, 55, 223 226.
3. El-Mansoury, M., Bryman, I., Berntorp, K., Hanson, C., Wilhelmsen, L. Landin-Wilhelmsen, K. (2005) Hypothyroidism is common in Turner syndrome - results of a five-year follow-up. Journal of Clinical Endocrinology and Metabolism, 90, 2131 2135.
4. Ivarsson, S.A., Carlsson, A., Bredberg, A., Alm, J., Aronsson, S., Gustafsson, J., Hagenäs, L., Häger, A., Kriström, B., Marcus, C., Moell, C., Nilsson, K.O., Tuvemo, T., Westphal, O., Albertsson-Wikland, K. Åman, J. (1999) Prevalence of celiac disease in Turner syndrome and growth hormone therapy. Acta Paediatrica, 88, 933 936.
5. Landin-Wilhelmsen, K., Bryman, I. Wilhelmsen, L. (2001) Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 4166 4170.
6. El-Mansoury, M., Barrenäs, M.-L., Bryman, I., Hanson, C., Larsson, C., Wilhelmsen, L. Landin-Wilhelmsen, K. (2007) Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome. Clinical Endocrinology, 66, 744 751.
7. Gravholt, C.H. (2004) Epidemiological, endocrine and metabolic features in Turner syndrome. European Journal of Endocrinology, 151, 657 687.
8. Sylvén, L., Hagenfeldt, K., Bröndum-Nielsen, K. von Schoultz, B. (1991) Middle-aged women with Turner's syndrome. Medical status, hormonal treatment and social life. Acta Endocrinologica, 125, 359 362.
9. Salerno, M., Di Maio, S., Gasparino, N., Rizzo, M., Ferri, P. Vajro, P. (1999) Liver abnormalities in Turner syndrome. European Journal of Endocrinology, 158, 618 623.
10. Roulot, D., Degott, C., Chazouillères, O., Oberti, F., Calès, P., Carbonell, N., Benferhat, S., Bresson-Hadni, S. Valla, D. (2004) Vascular involvement in the liver in Turner's syndrome. Hepatology, 39, 239 247.
11. O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., Parati, G., Pickering, T., Redon, J., Staessen, J., Stergiou, G. Verdecchia, P. on behalf of the European Society of Hypertension Working Group on blood pressure monitoring (2005) Practice guidelines of the European Society of Hypertension for clinical, ambulatory and self blood pressure measurement. Journal of Hypertension, 23, 697 701.
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) (2001) Journal of American Medical Association, 285, 2486 2497.
13. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report from a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva.
14. Friedewald, W.T., Levy, R.I. Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499 502.
15. Gravholt, C.H., Juul, S., Naeraa, R.N. Hansen, J. (1998) Morbidity in Turner syndrome. Journal of Clinical Epidemiology, 51, 147 158.
16. Albareda, M.M., Gallego, A., Enriquez, J., Rodriguez, J.L. Webb, S.M. (1999) Biochemical liver abnormalities in Turner's syndrome. European Journal of Gastroenterology and Hepatology, 11, 1037 1039.
17. Elsheikh, M., Hodgson, H.J., Wass, J.A. Conway, G.S. (2001) Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clinical Endocrinology, 55, 227 231.
18. Wilhelmsen, L., Johansson, S., Rosengren, A., Wallin, I., Dotevall, A. Lappas, G. (1997) Risk factors for cardiovascular disease during the period 1985-95 in Göteborg, Sweden, the GOT-MONICA Project. Journal of Internal Medicine, 242, 199 211.
19. Ostberg, J.E., Thomas, E.L., Hamilton, G., Attar, J.H., Bell, J.D. Conway, G.S. (2005) Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. Journal of Clinical Endocrinology and Metabolism, 90, 2631 2635.
20. Höjbjerg Gravholt, C., Eilersen Hjerrild, B., Mosekilde, L., Krarup Hansen, T., Melholt Rasmussen, L., Frystyk, J., Flyvbjerg, A. Sandahl Christiansen, L. (2006) Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. European Journal of Endocrinology, 155, 583 592.
21. Ekstedt, M., Franzén, L.E., Mathiesen, U.L., Holmqvist, M., Bodemar, G. Kechagias, S. (2007) Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. Journal of Hepatology, 47, 135 141.
22. Haas, J.S., Kaplan, C.P., Gerstenberger, E.P. Kerlikowske, K. (2004) Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Annals of Internal Medicine, 140, 184 188.
23. Bondy, C.A. for the Turner Syndrome Consensus Study Group (2007) Clinical Practice Guideline. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. Journal of Clinical Endocrinology and Metabolism, 92, 10 25.
24. Gravholt, C.H., Naeraa, R.W., Fisker, S. Christiansen, J.S. (1997) Body composition and physical fitness are major determinants of the growth hormone-IGF axis aberrations in adult Turner syndrome, with important modulations by treatment with 17-β-estradiol. Journal of Clinical Endocrinology and Metabolism, 82, 2570 2577.
25. Gravholt, C.H., Poulsen, H.E., Ott, P., Christiansen, J.S. Vilstrup, H. (2007) Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. European Journal of Endocrinology, 156, 679 686.
26. Saenger, P., Albertsson-Wikland, K., Conway, G., Davenport, M., Gravholt, C.H., Hintz, R., Hovatta, O., Hultcrantz, M., Landin-Wilhelmsen, K., Lin, A., Lippe, B., Pasquino, A.M., Ranke, M.B., Rosenfeld, R. Silberbach, M. (2001) Recommendations for the diagnosis and management of Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 3061 3069.